Skip to content

State Dependence of Prefrontal Transcranial Magnetic Stimulation

State Dependence of Prefrontal Transcranial Magnetic Stimulation

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05962385
Enrollment
51
Registered
2023-07-27
Start date
2023-08-24
Completion date
2025-11-17
Last updated
2025-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Brief summary

The study will examine whether the benefits of brain stimulation on mental functioning can be enhanced if an individual is actively engaging the target brain networks while receiving brain stimulation. The study includes two separate sessions and people will complete either a cognitive task or a perceptual task while receiving transcranial magnetic stimulation. The study will measure change in brain function with EEG.

Interventions

DEVICEBrain state while receiving TMS

Brain state whilst receiving TMS - cognitive control or perceptual. Repeated measures design, so all participants receive the same procedures.

Sponsors

University of Minnesota
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Masking description

No blinding is possible

Intervention model description

Repeated measures design - across two separate sessions (one week apart, counterbalanced between participants), participants will receive transcranial magnetic stimulation (TMS) whilst engaging in either a cognitive control or a perceptual task.

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Age 18 - 65, * healthy controls

Exclusion criteria

* Diagnosed psychiatric disorder * Potential contraindications to EEG (e.g. visible scalp abrasions, non-removable hair extensions and/or hair styling that would impede proper EEG recording) * Potential contraindication to TMS (as identified by the TMS safety screener) * Any previous adverse reaction to TMS or MRI * Diagnosed epilepsy or previously experienced a seizure * Diagnosed neurological condition, such as stroke or tinnitus * Experienced a head trauma that was diagnosed as concussion * Current use of, or recent withdrawal from, medications that can increase the risk of seizure * Currently pregnant * Any metal in the head (excluding mouth) * Any implanted medical device

Design outcomes

Primary

MeasureTime frameDescription
Theta-gamma cross frequency coupling0-500 ms after each TMS stimulusA metric of brain function measured with EEG - the coupling of theta oscillation phase with gamma power. This will be measured immediately following the intervention (TMS stimulation).
Cortical excitability60-300 ms after each TMS stimulusTMS-evoked potentials will be measured with EEG to examine cortical excitability after TMS. This will be measured immediately following the intervention (TMS stimulation).

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026